# New York Blood Center Inc – FDA Inspection, Sep 13, 2024

Source: https://www.keypedia.com/records/fda_inspections/new-york-blood-center-inc/f96d6a17-e836-46ce-bd75-d67db411cbec
Source feed: FDA_Inspections

> FDA inspection 1250041 of New York Blood Center Inc, September 13, 2024. Classification: No Action Indicated (NAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1250041
- Company Name: New York Blood Center Inc
- Inspection Date: 2024-09-13
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1078139 - 2019-01-30
- FDA Inspection 999367 - 2016-12-19
- FDA Inspection 899986 - 2014-10-10
- FDA Inspection 811526 - 2012-12-19
- FDA Inspection 728441 - 2011-06-08

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/amy-w-yan-mai/00551315-3a03-4327-ab3a-71de5c1577d4)

Company: https://www.keypedia.com/companies/new-york-blood-center-inc/eb0e1db5-2084-403d-86d5-00aa71babc9b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d